GeneDx Launches Easy Order to Streamline Pediatric Genomic Testing
Event summary
- GeneDx introduced Easy Order at the 2026 AAP National Conference to simplify genomic testing for pediatricians.
- The tool reduces required inputs and guides general pediatricians through the ordering process.
- AAP updated its guidance in 2025 to recommend exome or genome sequencing as a first-tier test for children with developmental delays.
- GeneDx is also developing Provider Report Guides to help non-genetics experts understand and communicate results.
The big picture
GeneDx's Easy Order launch aligns with the broader industry shift toward earlier genomic testing in pediatric care, driven by updated AAP guidelines. The tool addresses a critical gap in making genomic testing accessible to general pediatricians, who are often the first to identify developmental concerns. This move positions GeneDx to capitalize on the growing demand for streamlined, actionable genomic data in routine healthcare settings.
What we're watching
- Adoption Pace
- How quickly general pediatricians will integrate Easy Order into routine practice.
- Regulatory Shifts
- Whether expanded insurance coverage will accelerate the use of genomic testing in pediatric care.
- Competitive Dynamics
- The extent to which GeneDx can maintain its leadership position in rare disease diagnosis amid increasing competition.
Related topics
